Maria Feldman
Profile
Maria Feldman worked as Director of Regulatory Affairs at MediciNova, Inc., VP of Regulatory Affairs & Clinical Research at Neothetics, Inc., and VP of Clinical Research, Operations & Regulatory at Evofem Biosciences, Inc. She obtained an undergraduate degree from St. Olaf College.
Former positions of Maria Feldman
| Companies | Position | End |
|---|---|---|
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Chief Operating Officer | - |
| EVOFEM BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
| MEDICINOVA, INC. | General Counsel | - |
Training of Maria Feldman
| St. Olaf College | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| MEDICINOVA, INC. | Health Technology |
| EVOFEM BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Maria Feldman
